Qin Yan

Qin Yan

Yale University

H-index: 43

North America-United States

About Qin Yan

Qin Yan, With an exceptional h-index of 43 and a recent h-index of 35 (since 2020), a distinguished researcher at Yale University, specializes in the field of cancer epigenetics, metastasis, cancer immunology, breast cancer, melanoma.

His recent articles reflect a diverse array of research interests and contributions to the field:

ASCL1 Drives Tolerance to Osimertinib in EGFR Mutant Lung Cancer in Permissive Cellular Contexts

Combined BET and MEK Inhibition synergistically suppresses melanoma by targeting YAP1

Lysine Demethylation in Pathogenesis

KDM5 Lysine Demethylases in Pathogenesis, from Basic Science Discovery to the Clinic

Mammalian SWI/SNF chromatin remodeling complexes promote tyrosine kinase inhibitor resistance in EGFR-mutant lung cancer

The KDM6A-KMT2D-p300 axis regulates susceptibility to diverse coronaviruses by mediating viral receptor expression

DYRK1A promotes viral entry of highly pathogenic human coronaviruses in a kinase-independent manner

Epigenetic markers and therapeutic targets for metastasis

Qin Yan Information

University

Position

___

Citations(all)

7681

Citations(since 2020)

4342

Cited By

4679

hIndex(all)

43

hIndex(since 2020)

35

i10Index(all)

73

i10Index(since 2020)

66

Email

University Profile Page

Google Scholar

Qin Yan Skills & Research Interests

cancer epigenetics

metastasis

cancer immunology

breast cancer

melanoma

Top articles of Qin Yan

ASCL1 Drives Tolerance to Osimertinib in EGFR Mutant Lung Cancer in Permissive Cellular Contexts

Cancer Research

2024/4/15

Combined BET and MEK Inhibition synergistically suppresses melanoma by targeting YAP1

Theranostics

2024

Lysine Demethylation in Pathogenesis

2023/9/27

Jian Cao
Jian Cao

H-Index: 16

Qin Yan
Qin Yan

H-Index: 26

KDM5 Lysine Demethylases in Pathogenesis, from Basic Science Discovery to the Clinic

2023/9/27

Jian Cao
Jian Cao

H-Index: 16

Qin Yan
Qin Yan

H-Index: 26

Mammalian SWI/SNF chromatin remodeling complexes promote tyrosine kinase inhibitor resistance in EGFR-mutant lung cancer

Cancer Cell

2023/8/14

The KDM6A-KMT2D-p300 axis regulates susceptibility to diverse coronaviruses by mediating viral receptor expression

PLoS pathogens

2023/7/6

DYRK1A promotes viral entry of highly pathogenic human coronaviruses in a kinase-independent manner

PLoS biology

2023/6/13

Epigenetic markers and therapeutic targets for metastasis

2023/6

Qin Yan
Qin Yan

H-Index: 26

Design of Class I/IV Bromodomain-Targeting Degraders for Chromatin Remodeling Complexes

ACS Chemical Biology

2023/6/1

The crossroads of cancer epigenetics and immune checkpoint therapy

2023/4/3

Qin Yan
Qin Yan

H-Index: 26

Pharmacological disruption of mSWI/SNF complex activity restricts SARS-CoV-2 infection

Nature Genetics

2023/3

Epigenetically suppressed tumor cell intrinsic STING promotes tumor immune escape

Biomedicine & Pharmacotherapy

2023/1/1

Awakening KDM5B to defeat leukemia

Proceedings of the National Academy of Sciences

2022/3/29

Lok Hei Chan
Lok Hei Chan

H-Index: 5

Qin Yan
Qin Yan

H-Index: 26

CECR2 drives breast cancer metastasis by promoting NF-κB signaling and macrophage-mediated immune suppression

Science translational medicine

2022/2/2

Tick tock, tick tock: Mouse culture and tissue aging captured by an epigenetic clock

Aging Cell

2022/2

Nicotine dose-dependent epigenomic-wide DNA methylation changes in the mice with long-term electronic cigarette exposure

American Journal of Cancer Research

2022

Human WDR5 promotes breast cancer growth and metastasis via KMT2-independent translation regulation

Elife

2022/8/31

Epigenetic regulation and tumor immunotherapy

Frontiers in Oncology

2022

See List of Professors in Qin Yan University(Yale University)

Co-Authors

academic-engine